Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies

Cancer Treatment Reviews, 04/03/2012

Currently no valid practical biomarkers exist that can predict resistance to the taxanes in breast cancer supporting the principle of individualized cancer therapy. The incorporation of several biomarker analyses into prospectively designed studies in this setting are needed.

Print Article Summary Cat 2 CME Report